Rani Therapeutics Holdings, Inc. (RANI) insider trading.
In Q3 2026, insiders at Rani Therapeutics Holdings, Inc. reported 13 non-derivative transactions on 10 Forms 3, 4 and 5: 2 open-market purchases worth $50K and 2 sales worth $12K.
- Transactions
- 13
- Purchases (P)
- 2
- Sales (S)
- 2
- Net shares, P minus S
- 62,600
- Insiders
- 3
- Last filed
- 2026-09-29
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Imran Talat | Director, Officer · Chief Executive Officer | 9 | 1 | 1 |
| Javadi Alireza | Officer · Chief Technical Officer | 3 | 0 | 1 |
| Imran Mir A | Director, TenPercentOwner | 1 | 1 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-27 | Javadi Alireza | F (D) | 309 | $0.76 | 9,071 | Form 4 |
| 2026-09-27 | Imran Talat | F (D) | 7,928 | $0.76 | 461,808 | Form 4 |
| 2026-07-21 | Imran Mir A | P (A) | 36,000 | $0.69 | 2,119,334 | Form 4 |
| 2026-07-17 | Imran Talat | P (A) | 35,000 | $0.72 | 469,736 | Form 4 |
| 2026-06-27 | Imran Talat | F (D) | 7,927 | $0.74 | 434,736 | Form 4 |
| 2026-06-27 | Javadi Alireza | F (D) | 309 | $0.74 | 9,380 | Form 4 |
| 2026-03-27 | Imran Talat | F (D) | 9,099 | $0.81 | 442,663 | Form 4 |
| 2026-03-27 | Javadi Alireza | S (D) | 386 | $0.78 | 9,689 | Form 4 |
| 2026-03-22 | Imran Talat | F (D) | 8,916 | $1.13 | 451,762 | Form 4 |
| 2025-12-27 | Imran Talat | F (D) | 7,906 | $1.4 | 460,678 | Form 4 |
| 2025-09-27 | Imran Talat | F (D) | 9,077 | $0.48 | 468,584 | Form 4 |
| 2025-06-27 | Imran Talat | F (D) | 9,076 | $0.55 | 477,661 | Form 4 |
| 2024-12-27 | Imran Talat | S (D) | 8,014 | $1.41 | 486,737 | Form 4 |
Transaction codes in this quarter
Get RANI insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1856725&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · RANI company page · Rani Therapeutics Holdings, Inc. on SEC.gov
Questions
Are insiders buying or selling Rani Therapeutics Holdings, Inc. (RANI)?
In Q3 2026, insiders at Rani Therapeutics Holdings, Inc. reported 13 non-derivative transactions on 10 Forms 3, 4 and 5: 2 open-market purchases worth $50K and 2 sales worth $12K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Rani Therapeutics Holdings, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/rani.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.